Silk Road Medical Stock Forecast, Price & News

Silk Road Medical (NASDAQ:SILK) Frequently Asked Questions

Is Silk Road Medical a buy right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Silk Road Medical in the last year. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" Silk Road Medical stock.
View analyst ratings for Silk Road Medical or view top-rated stocks.

How has Silk Road Medical's stock been impacted by COVID-19 (Coronavirus)?

Silk Road Medical's stock was trading at $37.14 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SILK shares have decreased by 14.4% and is now trading at $31.78.
View which stocks have been most impacted by COVID-19.

Are investors shorting Silk Road Medical?

Silk Road Medical saw a drop in short interest in the month of December. As of December 15th, there was short interest totaling 1,960,000 shares, a drop of 16.6% from the November 30th total of 2,350,000 shares. Based on an average daily volume of 270,800 shares, the days-to-cover ratio is presently 7.2 days. Currently, 5.8% of the company's stock are sold short.
View Silk Road Medical's Short Interest.

When is Silk Road Medical's next earnings date?

Silk Road Medical is scheduled to release its next quarterly earnings announcement on Monday, March 7th 2022.
View our earnings forecast for Silk Road Medical.

How were Silk Road Medical's earnings last quarter?

Silk Road Medical, Inc (NASDAQ:SILK) announced its quarterly earnings results on Tuesday, November, 9th. The company reported ($0.40) earnings per share (EPS) for the quarter, missing the Zacks' consensus estimate of ($0.31) by $0.09. The firm had revenue of $24.70 million for the quarter, compared to the consensus estimate of $26.03 million. Silk Road Medical had a negative trailing twelve-month return on equity of 52.81% and a negative net margin of 54.99%. During the same quarter in the previous year, the firm earned ($0.31) EPS.
View Silk Road Medical's earnings history.

What guidance has Silk Road Medical issued on next quarter's earnings?

Silk Road Medical issued an update on its FY 2021 earnings guidance on Tuesday, December, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $99 million-$102 million, compared to the consensus revenue estimate of $103.23 million.

What price target have analysts set for SILK?

4 analysts have issued 1-year target prices for Silk Road Medical's shares. Their forecasts range from $48.00 to $66.00. On average, they expect Silk Road Medical's stock price to reach $56.00 in the next twelve months. This suggests a possible upside of 76.2% from the stock's current price.
View analysts' price targets for Silk Road Medical or view top-rated stocks among Wall Street analysts.

Who are Silk Road Medical's key executives?

Silk Road Medical's management team includes the following people:

• Erica J. Rogers, President, Chief Executive Officer & Director (LinkedIn Profile)
• Lucas W. Buchanan, Chief Financial & Operating Officer (LinkedIn Profile)
• Sumaira Macdonald, Executive Medical Director
• Tammy Leitsinger, VP-Professional Education & Medical Affairs
• Robert A. Nicholas, Vice President-Operations & Engineering

Who are some of Silk Road Medical's key competitors?

Some companies that are related to Silk Road Medical include iRhythm Technologies (IRTC), Inari Medical (NARI), Merit Medical Systems (MMSI), Nevro (NVRO), NuVasive (NUVA), AtriCure (ATRC), Haemonetics (HAE), Glaukos (GKOS), Axonics (AXNX), Beauty Health (SKIN), Atrion (ATRI), Paragon 28 (FNA), Bioventus (BVS), Alphatec (ATEC) and Treace Medical Concepts (TMCI).
View all of SILK's competitors.

What other stocks do shareholders of Silk Road Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Silk Road Medical investors own include Raytheon Technologies (RTX), Procter & Gamble (PG), Abbott Laboratories (ABT), Cisco Systems (CSCO), Pfizer (PFE), Edwards Lifesciences (EW), (HON), CSX (CSX), Thermo Fisher Scientific (TMO) and Alibaba Group (BABA).

When did Silk Road Medical IPO?

(SILK) raised $75 million in an initial public offering (IPO) on Thursday, April 4th 2019. The company issued 4,700,000 shares at $15.00-$17.00 per share. J.P. Morgan and BofA Merrill Lynch served as the underwriters for the IPO and BMO Capital Markets and Stifel were co-managers.

What is Silk Road Medical's stock symbol?

Silk Road Medical trades on the NASDAQ under the ticker symbol "SILK."

How do I buy shares of Silk Road Medical?

Shares of SILK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Silk Road Medical's stock price today?

One share of SILK stock can currently be purchased for approximately $31.78.

How much money does Silk Road Medical make?

Silk Road Medical has a market capitalization of $1.11 billion and generates $75.23 million in revenue each year. The company earns $-47.37 million in net income (profit) each year or ($1.51) on an earnings per share basis.

How many employees does Silk Road Medical have?

Silk Road Medical employs 281 workers across the globe.

What is Silk Road Medical's official website?

The official website for Silk Road Medical is www.silkroadmed.com.

Where are Silk Road Medical's headquarters?

Silk Road Medical is headquartered at 1213 INNSBRUCK DR., SUNNYVALE CA, 94089.

How can I contact Silk Road Medical?

Silk Road Medical's mailing address is 1213 INNSBRUCK DR., SUNNYVALE CA, 94089. The company can be reached via phone at (408) 720-9002, via email at [email protected], or via fax at 408-720-9013.